Your browser doesn't support javascript.
loading
Genetics of Ataxias in Indian Population: A Collative Insight from a Common Genetic Screening Tool.
Sharma, Pooja; Sonakar, Akhilesh Kumar; Tyagi, Nishu; Suroliya, Varun; Kumar, Manish; Kutum, Rintu; Asokchandran, Vivekananda; Ambawat, Sakshi; Shamim, Uzma; Anand, Avni; Ahmad, Ishtaq; Shakya, Sunil; Uppili, Bharathram; Mathur, Aradhana; Parveen, Shaista; Jain, Shweta; Singh, Jyotsna; Seth, Malika; Zahra, Sana; Joshi, Aditi; Goel, Divya; Sahni, Shweta; Kamai, Asangla; Wadhwa, Saruchi; Murali, Aparna; Saifi, Sheeba; Chowdhury, Debashish; Pandey, Sanjay; Anand, Kuljeet Singh; Narasimhan, Ranganathan Lakshmi; Laskar, Sanghamitra; Kushwaha, Suman; Kumar, Mukesh; Shaji, Cheruvallill Velayudhan; Srivastava, Madakasira Vasantha Padma; Srivastava, Achal K; Faruq, Mohammed.
Affiliation
  • Sharma P; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Sonakar AK; Academy for Scientific and Innovative Research Ghaziabad Uttar Pradesh 201002 India.
  • Tyagi N; Neurology Department Neuroscience Centre New Delhi 110029 India.
  • Suroliya V; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Kumar M; Academy for Scientific and Innovative Research Ghaziabad Uttar Pradesh 201002 India.
  • Kutum R; Neurology Department Neuroscience Centre New Delhi 110029 India.
  • Asokchandran V; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Ambawat S; Academy for Scientific and Innovative Research Ghaziabad Uttar Pradesh 201002 India.
  • Shamim U; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Anand A; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Ahmad I; Academy for Scientific and Innovative Research Ghaziabad Uttar Pradesh 201002 India.
  • Shakya S; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Uppili B; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Mathur A; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Parveen S; Neurology Department Neuroscience Centre New Delhi 110029 India.
  • Jain S; Neurology Department Neuroscience Centre New Delhi 110029 India.
  • Singh J; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Seth M; Academy for Scientific and Innovative Research Ghaziabad Uttar Pradesh 201002 India.
  • Zahra S; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Joshi A; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Goel D; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Sahni S; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Kamai A; Neurology Department Neuroscience Centre New Delhi 110029 India.
  • Wadhwa S; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Murali A; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Saifi S; Academy for Scientific and Innovative Research Ghaziabad Uttar Pradesh 201002 India.
  • Chowdhury D; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Pandey S; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Anand KS; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Narasimhan RL; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Laskar S; Academy for Scientific and Innovative Research Ghaziabad Uttar Pradesh 201002 India.
  • Kushwaha S; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Kumar M; Academy for Scientific and Innovative Research Ghaziabad Uttar Pradesh 201002 India.
  • Shaji CV; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Srivastava MVP; Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) Mall Road Delhi 110007 India.
  • Srivastava AK; Department of Neurology GB Pant Hospital Delhi 110002 India.
  • Faruq M; Department of Neurology GB Pant Hospital Delhi 110002 India.
Adv Genet (Hoboken) ; 3(2): 2100078, 2022 Jun.
Article in En | MEDLINE | ID: mdl-36618024
ABSTRACT
Cerebellar ataxias (CAs) represent a group of autosomal dominant and recessive neurodegenerative disorders affecting cerebellum with or without spinal cord. Overall, CAs have preponderance for tandem nucleotide repeat expansions as an etiological factor (10 TREs explain nearly 30-40% of ataxia cohort globally). The experience of 10 years of common genetic ataxia subtypes for ≈5600 patients' referrals (Pan-India) received at a single center is shared herein. Frequencies (in %, n) of SCA types and FRDA in the sample cohort are observed as follows SCA12 (8.6%, 490); SCA2 (8.5%, 482); SCA1 (4.8%, 272); SCA3 (2%, 113); SCA7 (0.5%, 28); SCA6 (0.1%, 05); SCA17 (0.1%, 05), and FRDA (2.2%, 127). A significant amount of variability in TRE lengths at each locus is observed, we noted presence of biallelic expansion, co-occurrence of SCA-subtypes, and the presence of premutable normal alleles. The frequency of mutated GAA-FRDA allele in healthy controls is 1/158 (0.63%), thus an expected FRDA prevalence of 1100 000 persons. The data of this study are relevant not only for clinical decision making but also for guidance in direction of genetic investigations, transancestral comparison of genotypes, and lastly provide insight for policy decision for the consideration of SCAs under rare disease category.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Language: En Journal: Adv Genet (Hoboken) Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Language: En Journal: Adv Genet (Hoboken) Year: 2022 Document type: Article